Doctors Without Borders Pricing Analysis Also Extends to HIV Diagnostic and Monitoring Tools
Download Report [4.86 MB]
LUMPUR/NEW YORK—(ENEWSPF)–JULY 2, 2013—The price of first- and second-line antiretrovirals (ARVs) to treat HIV are falling because of increased competition among generic producers, but newer ARVs continue to be priced astronomically high, according to the annual report Untangling the Web of ARV Price Reductions, released today by the international medical humanitarian organization Doctors…
